Group 1 - Fuda Alloy's controlling shareholder Wang Dawu plans to reduce his stake by up to 3% of the company's total shares, amounting to a maximum of 406.34 million shares, due to personal funding needs [1] - ST Songfa's subsidiary signed contracts for the construction of 17 vessels, with a total contract value between 1.6 billion to 1.8 billion USD [2] - Pairui Co. signed a technical cooperation agreement with a university to develop large-capacity power semiconductor devices and related power electronic modules, effective for three years [3] Group 2 - Shuangliang Energy indirectly participates in commercial aerospace projects, supplying heat exchangers for SpaceX's fuel production system, with orders totaling approximately 1.39 million CNY [4] - Hangya Technology plans to issue convertible bonds to raise up to 600 million CNY for various projects, including an intelligent manufacturing base in Malaysia [5] - Yuhua Development is publicly selling assets with a base price of 251 million CNY for residential properties [6] Group 3 - Penghui Energy plans to invest 2.1 billion CNY in a new battery production project in Zhengyang County, Henan Province, focusing on high-performance battery products [7] - Haige Communication's shareholder Yang Haizhou intends to reduce his stake by up to 0.1624% of the company's total shares [8] - Yaoshi Technology's controlling shareholder pledged 5.13% of shares to repay loans, with a pledge period from February 10, 2026, to February 2, 2027 [9][10] Group 4 - Hanyu Pharmaceutical received FDA approval for its drug Acetate Glatiramer Injection, used for treating relapsing multiple sclerosis [11] - Baiyao Tai's GoliMab Injection received EMA approval for various indications, including rheumatoid arthritis and ulcerative colitis [12] - Jiangxi Tungsten Equipment plans to issue A-shares to raise up to 1.882 billion CNY for acquisitions [13] Group 5 - Hesong New Materials expects to recognize asset impairment provisions between 23.6 million to 28.5 million CNY for 2025 [14] - ST Meichen's subsidiary is involved in two major lawsuits with a total amount of approximately 31.9 million CNY [15] - China Coal Energy reported a 7.3% year-on-year decline in coal sales for January 2026, with total sales of 20.05 million tons [16] Group 6 - Yida Co. plans to adjust its epoxy propylene derivative project, reducing the total investment from 845 million CNY to 642 million CNY [17] - Fosun Pharma's subsidiary received approval for a clinical trial of HLX15-SC for multiple myeloma treatment [18][19] - Yinfeng Communication's board members and executives have terminated their share reduction plan [20] Group 7 - Huazhong High-tech has waived its preferential purchase rights for a fund, extending the investment period from three to four years [21] - Warner Pharmaceuticals plans to participate in a national drug procurement program, with expected sales of 176 million CNY [22] - Changling Hydraulic announced a tender offer to acquire 12% of its shares at a price of 35.82 CNY per share [23] Group 8 - ST Chuan Zhi's stock may face delisting due to financial data falling below regulatory thresholds [24] - Tian Pharmaceutical and its subsidiaries are participating in a national drug procurement program, with expected sales of 323 million CNY [25] - China Metallurgical Group signed new contracts worth 73.65 billion CNY in January 2026 [26] Group 9 - Torus plans to invest 21.2 million CNY in a venture capital fund focused on artificial intelligence [27] - Shangwei Co. received a government subsidy of 1.764 million CNY, representing 10.79% of its net profit for 2024 [28] - Hanghua Co. reported a 21.97% decline in net profit for 2025, with total revenue of 1.249 billion CNY [29] Group 10 - Huaxia Bank reported a 1.72% decline in net profit for 2025, with total revenue of 91.914 billion CNY [30] - Guotou Fengle plans to transfer 51% of its stake in Hubei Fengle Ecological Fertilizer to optimize management [31] - Huaru Technology is co-investing in a fund with a total commitment of 20 million CNY [32] Group 11 - Jindike reported a loss of 173 million CNY for 2025, despite a 40.13% increase in revenue [33] - Zhenong Co. announced a 0.52% increase in shares held by a major shareholder [34] - Maike Audi plans to recognize asset impairment provisions of approximately 52.55 million CNY [35] Group 12 - Fuan Pharmaceutical's subsidiary is expected to be selected for a national drug procurement program, with projected sales of 680 million CNY [36] - Rundu Co. is participating in a national drug procurement program, with some products expected to be selected [37] - Changqing Co. has postponed its large-scale die-casting project to March 2027 due to customer requirements [38] Group 13 - Pan Asia Micro透 received a patent for a graphene-based automotive headlight defogging device [39] - Luan An Huan Neng reported a 17.1% increase in raw coal production for January 2026, totaling 5 million tons [40] - Guangji Pharmaceutical received a drug registration certificate for Mecobalamin Tablets [41] Group 14 - Ruifeng New Materials announced the resignation of its deputy general manager for personal reasons [42] - Zhiguang Electric's subsidiary signed a procurement contract for energy storage equipment worth 210.4 million CNY [43] - Youyan Powder Materials reported a 19.41% increase in net profit for 2025 [44] Group 15 - Jincheng reported a 22.2% increase in net profit for 2025, with total revenue of 253 million CNY [46]

Group 1 - The company, Ruifeng New Materials, announced the resignation of its Vice President, Wang Shaohui, due to personal reasons [2] - Wang Shaohui's term was originally set to last until the expiration of the fourth board of directors on July 4, 2027 [2]

Core Viewpoint - The company announced the resignation of its Vice President Wang Shaohui due to personal reasons, which will not affect the company's normal operations and management [1] Group 1 - Wang Shaohui's original term as Vice President was set to end on July 4, 2027 [1] - After resigning from the Vice President position, Wang Shaohui will continue to hold a position within the company [1] - As of the announcement date, Wang Shaohui holds 1.2421 million shares of the company, accounting for 0.42% of the total share capital [1]

证券代码：300910 证券简称：瑞丰新材 公告编号：2026-002 关于公司副总经理辞职的公告 公司董事会对王少辉先生在任职期间的勤勉尽责、辛勤付出以及为公司规范 运作、稳健发展所做出的贡献表示衷心的感谢！ 特此公告。 新乡市瑞丰新材料股份有限公司董事会 2026年2月12日 本公司及董事会全体成员保证信息披露的内容真实、准确、完整，没有虚 假记载、误导性陈述或重大遗漏。 新乡市瑞丰新材料股份有限公司（以下简称"公司"）董事会于近日收到公 司副总经理王少辉先生递交的书面辞职报告。王少辉先生因个人原因辞去公司副 总经理职务。王少辉先生担任公司副总经理的原定任期至第四届董事会届满之日 （2027年7月4日）为止。根据《公司法》《深圳证券交易所上市公司自律监管指 引第2号——创业板上市公司规范运作》《公司章程》等相关规定，王少辉先生 的辞职申请自送达董事会之日起生效，其辞职不会对公司的正常运作及经营管理 产生影响。王少辉先生辞去副总经理职务后仍将在公司任职。 截至本公告披露日，王少辉先生持有公司股份1,242,107股，占公司总股本的 0.42%。王少辉先生不存在应当履行而未履行的承诺事项。辞职后，王少辉先生 ...

Investment Rating - The report maintains a "Buy" rating for several companies including Xinyangfeng, Senqilin, Ruifeng New Materials, Sinopec, Juhua, Yangnong Chemical, CNOOC, Tongkun, Daotong Technology, and others [10]. Core Views - The report highlights significant price increases in products such as p-nitrochlorobenzene (up 27.91%) and LLDPE (up 24.72%), while products like natural gas and LDPE saw substantial declines [6][18]. - It suggests focusing on investment opportunities in areas such as import substitution, domestic demand, and high dividend stocks, particularly in light of fluctuating international oil prices [6][19]. - The report anticipates that international oil prices will stabilize around $65 per barrel in 2026, influenced by geopolitical uncertainties and expectations of price declines [19]. Summary by Sections Product Price Movements - Notable price increases this week include p-nitrochlorobenzene (27.91%), LLDPE (24.72%), and liquid chlorine (20.90) [18]. - Conversely, significant declines were observed in natural gas (-22.34%) and LDPE (-18.02%) [5][21]. Industry Performance - The chemical industry remains in a weak position overall, with mixed performance across sub-sectors due to past capacity expansions and weak demand [21]. - Specific sectors like the glyphosate industry are showing signs of potential recovery, with decreasing inventories and rising prices, suggesting a possible entry into a favorable cycle [21]. Investment Recommendations - The report recommends focusing on companies with strong competitive positions and growth potential, such as Ruifeng New Materials and Baofeng Energy [21]. - It emphasizes the importance of domestic chemical fertilizer and pesticide sectors, which are expected to maintain stable demand due to self-sufficiency [21]. - The report also highlights the benefits for major oil companies like Sinopec, which are expected to gain from lower raw material costs due to declining oil prices [21].

Group 1 - The company, Ruifeng New Materials (300910), responded to investor inquiries on January 30, indicating that it adheres to the disclosure standards set by the Shenzhen Stock Exchange's ChiNext listing rules regarding performance forecasts [1] - The company confirmed that it will fulfill its information disclosure obligations if it meets the relevant standards outlined in the regulations [1]

截至2026年1月30日 11:20，中证细分化工产业主题指数下跌2.55%。成分股方面涨跌互现，恩捷股份领 涨4.25%，瑞丰新材上涨0.34%，宝丰能源上涨0.25%；华峰化学领跌，和邦生物、藏格矿业跟跌。 长期以来，传统化工行业因无序扩产导致产能严重过剩，成为压制盈利的核心症结。2025–2026年，供 给端迎来根本性变革：国家出台《石化化工行业稳增长工作方案（2025—2026年）》，明确遏制盲目投 资、推动落后产能有序退出，各地配套政策同步落地。在此引导下，行业自发开启"反内卷"模式——企 业主动安排装置检修、收缩低效产能。 数据显示，截至2025年12月31日，中证细分化工产业主题指数前十大权重股分别为万华化学、盐湖股 份、藏格矿业、天赐材料、巨化股份、恒力石化、华鲁恒升、宝丰能源、云天化、金发科技，前十大权 重股合计占比45.31%。 化工ETF嘉实(159129)紧密跟踪中证细分化工产业主题指数，聚焦行业"反内卷"背景下新一轮景气周 期。 场外投资者还可以通过化工ETF联接基金(013527)关注化工板块投资机遇。 国海证券指出，展望2026年，中国化工行业推行反内卷，化工有望迎来景气上行周期 ...

Group 1 - The overall market is experiencing fluctuations influenced by overnight U.S. stock movements, with capital entering the chemical sector at lower prices, as evidenced by a net subscription of 62 million units for the chemical ETF (159870), marking 22 consecutive days of net inflow [1] - Enjie Co., Ltd. announced an expected net profit attributable to shareholders of 109 million to 164 million yuan for 2025, recovering from a loss of 556 million yuan in the same period last year, driven by sustained growth in downstream demand for lithium battery separator membranes [1] - Dongwu Securities highlighted that the price for 6F long-term contracts is nearly 150,000 yuan/ton, with lithium iron phosphate processing fees last week ranging from 1,500 to 2,000 yuan/ton, and small customers of separators seeing price increases of 20-40%, maintaining a positive outlook on the price elasticity of the lithium battery sector and quality material leaders [1] Group 2 - As of December 31, 2025, the top ten weighted stocks in the CSI Sub-Industry Chemical Theme Index (000813) include Wanhua Chemical, Salt Lake Industry, and others, with these stocks collectively accounting for 45.31% of the index [2] - The CSI Sub-Industry Chemical Theme Index closely tracks the performance of major listed companies in the chemical sector, selected based on size and liquidity from various sub-industries [2]

Group 1 - The core viewpoint of the articles indicates that the chemical materials sector is experiencing a shift from a "cost-sensitive" model to a "structural growth" model, driven by policies on carbon emissions, global energy transitions, and domestic manufacturing recovery [1] - The China Securities Index shows that the chemical industry index rose by 7.29% last week, outperforming the CSI 300 index by 7.91 percentage points, with all 24 sub-industries within the sector recording gains [1] - The implementation of a dual control system for carbon emissions in China marks a new phase in institutionalizing green and low-carbon development, which is expected to accelerate the elimination of outdated capacity in high-energy-consuming and high-emission chemical sub-industries [1] Group 2 - As of December 31, 2025, the top ten weighted stocks in the China Securities Index for the chemical industry include Wanhua Chemical, Salt Lake Co., and Cangge Mining, with these stocks collectively accounting for 45.31% of the index [2] - The chemical ETF managed by Harvest (159129) closely tracks the China Securities Index for the chemical industry, focusing on the new round of prosperity cycle against the backdrop of "anti-involution" in the industry [2] - Investors can also explore investment opportunities in the chemical sector through the chemical ETF linked fund (013527) [3]

Group 1 - The company, Ruifeng New Materials, has received the "High-tech Enterprise Certificate" issued by the Henan Provincial Department of Science and Technology, Henan Provincial Department of Finance, and the State Taxation Administration of Henan Province [2] - The certificate number is GR202541002056, and it was issued on November 4, 2025, with a validity period of three years [2] - This recognition is a renewal of the company's previous "High-tech Enterprise Certificate" that had expired [2]